CGS-19281A
| Nazivi | |
|---|---|
| Preferisani IUPAC naziv
7-metoksi-4,9-dihidro-3H-pirido[3,4-b]indol | |
| Drugi nazivi
4,9-dihidro-7-metoksi-3H-pirido(3,4b)indol • CGS 19281A • Cgs-19281A • 31652-37-6 • 4,9-Dihidro-7-metoksi-3H-pirido(3,4b)indol • CHEMBL6409 • Cgs 19281A • 3H-Pirido(3,4-b)indol, 4,9-dihidro-7-metoksi- • SCHEMBL2930783 • DTXSID90185537 • BDBM50079903 • 7-Metoksi-4,9-dihidro-3H-beta-karbolin
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C12H12N2O | |
| Molarna masa | 200,24 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
CGS-19281A ispoljava antihipertenzivne efekte inhibicijom feniletanolamin-N-metiltransferaze.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ R E Chatelain; et al. (1990). „Antihypertensive effects of CGS 19281A, an inhibitor of phenylethanolamine-N-methyltransferase”. J Pharmacol Exp Ther. 252 (1): 117—25.